Abstract
Background There is a growing movement to implement learning health systems (LHS), in which real-time evidence, informatics, patient-provider partnerships and experiences, and organizational culture are aligned to support improvements in care. However, what constitutes a LHS varies based on context and capacity, hindering standardization, scale-up, and knowledge sharing. Further, LHS often use “usual care” as the benchmark for comparing new approaches to care, but disentangling usual care from multifarious care modalities found across settings is challenging. To advance robust LHS, a comprehensive overview of existing LHS including strengths and opportunities for growth is needed.
Objectives To scope and identify international existing LHS to: 1) inform the global landscape of LHS, highlight common strengths, and identify opportunities for growth or improvement; and 2) identify common characteristics, emphases, assumptions, or challenges described in establishing counterfactuals in LHS.
Methods A jurisdictional scan will be conducted according to modified PRISMA guidelines. LHS will be identified through a search of peer-reviewed and grey literature using Ovid Medline, Ebsco CINAHL, Ovid Embase, Clarivate Web of Science, and PubMed Non-Medline databases and the web along with informal discussions with peer LHS experts. Self-identified LHS will be included if they are described in sufficient detail, either in literature or during informal discussions, according to ≥4 of 10 criteria (core functionalities, analytics, use of evidence, co-design/implementation, evaluation, change management/governance structures, data sharing, knowledge sharing, training/capacity building, equity, sustainability) in an existing framework to characterize LHS. Search results will be screened, extracted, and analyzed to inform two descriptive reviews pertaining to our two main objectives. Data will be extracted according to a pre-specified extraction form and summarized descriptively.
Implications This research will characterize the current landscape of worldwide LHS and provide a foundation for promoting knowledge and resource sharing, identifying next steps for the growth, improvement, and evaluation of LHS.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
NA
Funding Statement
The author(s) received no specific funding for this work.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
NA
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
No datasets were generated or analysed during the current study. All relevant data from this study will be made available upon study completion.
